NDC 0009-0317-11 - Heparin Sodium

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0009-0317
Requested NDC: 0009-0317-11
Package NDCs from labels: 0009-0317-02, 0009-0317-11, 0009-0317-10
Effective date: 2006-04-13
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Heparin Sodium Injection, USP		2006-04-13	HUMAN PRESCRIPTION DRUG LABELING

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0009-0317-02	Heparin Sodium	4 mL in 1 VIAL	INJECTION, SOLUTION	4	1
0009-0317-10	Heparin Sodium	1 mL in 1 VIAL	INJECTION, SOLUTION	1	1
0009-0317-10	Heparin Sodium	25 in 1 PACKAGE	INJECTION, SOLUTION	25	1
0009-0317-11	Heparin Sodium	25 in 1 PACKAGE	INJECTION, SOLUTION	25	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0009-0317	HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION [PHARMACIA & UPJOHN COMPANY]	1	4 package rows	20071212_EFCDB321-832B-4554-8049-DBBB33B48334.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Heparin Sodium	ACTIVE INGREDIENT	ZZ45AB24CA	HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION	1
Heparin	ACTIVE MOIETY	T2410KM04A	HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION	1
benzyl alcohol	INACTIVE INGREDIENT	LKG8494WBH	HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION	1
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 29 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Heparin Sodium	HEPARIN SODIUM	Cardinal Health 107, LLC	239b4816-6a55-451b-bf40-e611be07d12f	2026-08-10	Warnings, Adverse reactions	Exact identifier rxcui: 1361226
Heparin Sodium	HEPARIN SODIUM	Cardinal Health 107, LLC	e0cc5f44-9a67-4274-a48a-d6118e96d391	2026-06-25	Warnings, Adverse reactions	Exact identifier rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Cardinal Health 107, LLC	f67eea4e-80ff-48da-8b04-8addc5cd31d1	2026-05-12	Warnings, Adverse reactions	Exact identifier rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Fresenius Kabi USA, LLC	2a173253-dfdc-4d9d-8dee-b9c13e6fa9f5	2026-04-30	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1362831 rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Plano Pharmaceuticals Inc.	4deaa9ac-91aa-d96b-e063-6294a90a47bd	2026-03-25	Warnings, Adverse reactions	Exact identifier rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Hospira, Inc.	6c181d7e-aed2-4975-30ac-d39a94cca7ec	2026-03-24	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Medical Purchasing Solutions, LLC	4c118b39-cb4e-31a9-e063-6394a90a41b0	2026-03-02	Warnings, Adverse reactions	Exact identifier rxcui: 1361226
Heparin Sodium	HEPARIN SODIUM	Medical Purchasing Solutions, LLC	463e0624-b8c3-386b-e063-6294a90afd28	2025-12-18	Warnings, Adverse reactions	Exact identifier rxcui: 1361226
Heparin Sodium	HEPARIN SODIUM	Fresenius Kabi USA, LLC	d55b4a63-0c04-4874-b74f-9e9b9e8b008c	2025-11-28	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1362831 rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Fresenius Kabi USA, LLC	ed937dd2-8fab-4875-a1e8-627b71ccb7fb	2025-11-27	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Sagent Pharmaceticals	ef309d83-7262-4874-8580-f4ca254f963a	2025-11-18	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1362831 rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Sagent Pharmaceuticals	8ebe4b4d-cb28-47e8-9598-6105d250b3d2	2025-11-18	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1362831 rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Henry Schein, Inc.	3a998729-c912-4e21-8e49-d1e72ba6fe9e	2025-10-31	Warnings, Adverse reactions	Exact identifier rxcui: 1361226
Heparin Sodium	HEPARIN SODIUM	Pfizer Laboratories Div Pfizer Inc	56dc3074-f1c5-45a3-b923-f1d14858e06d	2025-10-03	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1362831 rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Meitheal Pharmaceuticals Inc.	02fb700d-a28c-4d45-b78d-382dc0d5986c	2025-09-26	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1362831 rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Medical Purchasing Solutions, LLC	3edf9198-b88d-7808-e063-6394a90ae89c	2025-09-15	Warnings, Adverse reactions	Exact identifier rxcui: 1361226
Heparin Sodium	HEPARIN SODIUM	Medical Purchasing Solutions, LLC.	3ea2bd53-ed13-a516-e063-6394a90a5dd9	2025-09-12	Warnings, Adverse reactions	Exact identifier rxcui: 1361226
Heparin Sodium	HEPARIN SODIUM	Hikma Pharmaceuticals USA Inc.	7014808d-cec9-4b2c-8eb5-940493e356ab	2025-08-13	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1362831 rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	NorthStar RxLLC	c4fa6d34-e76b-4c3c-b74d-21ce41432a04	2025-05-29	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1361615
Heparin Sodium	HEPARIN SODIUM	Mylan Institutional LLC	88114716-5759-4bc9-8a85-d28da12962cc	2025-04-15	Warnings, Adverse reactions	Exact identifier rxcui: 1361226 rxcui: 1362831 rxcui: 1361615

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.